ATE237680T1 - Transplantation von hämatopoietischen zellen - Google Patents

Transplantation von hämatopoietischen zellen

Info

Publication number
ATE237680T1
ATE237680T1 AT00905194T AT00905194T ATE237680T1 AT E237680 T1 ATE237680 T1 AT E237680T1 AT 00905194 T AT00905194 T AT 00905194T AT 00905194 T AT00905194 T AT 00905194T AT E237680 T1 ATE237680 T1 AT E237680T1
Authority
AT
Austria
Prior art keywords
transplantation
hematopoietic cells
disease
treatment
stem cells
Prior art date
Application number
AT00905194T
Other languages
English (en)
Inventor
Jack Price
Original Assignee
Reneuron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reneuron Ltd filed Critical Reneuron Ltd
Application granted granted Critical
Publication of ATE237680T1 publication Critical patent/ATE237680T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00905194T 1999-02-24 2000-02-23 Transplantation von hämatopoietischen zellen ATE237680T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9904281.4A GB9904281D0 (en) 1999-02-24 1999-02-24 Transplantation
PCT/GB2000/000636 WO2000050568A2 (en) 1999-02-24 2000-02-23 Transplantation of haematopoietic cells

Publications (1)

Publication Number Publication Date
ATE237680T1 true ATE237680T1 (de) 2003-05-15

Family

ID=10848438

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00905194T ATE237680T1 (de) 1999-02-24 2000-02-23 Transplantation von hämatopoietischen zellen

Country Status (20)

Country Link
EP (1) EP1161521B1 (de)
JP (1) JP4716575B2 (de)
KR (1) KR20020000216A (de)
CN (1) CN1636053A (de)
AT (1) ATE237680T1 (de)
AU (1) AU762763B2 (de)
CA (1) CA2361401A1 (de)
CZ (1) CZ20012651A3 (de)
DE (1) DE60002185T2 (de)
DK (1) DK1161521T3 (de)
ES (1) ES2193938T3 (de)
GB (1) GB9904281D0 (de)
HK (1) HK1041284B (de)
HU (1) HUP0105168A3 (de)
NO (1) NO20014091D0 (de)
PL (1) PL350297A1 (de)
PT (1) PT1161521E (de)
RU (1) RU2216336C2 (de)
SK (1) SK11232001A3 (de)
WO (1) WO2000050568A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9518606D0 (en) 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
US8017112B2 (en) 1999-05-14 2011-09-13 Henry Ford Health System Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
ES2531592T3 (es) * 1999-05-14 2015-03-17 Henry Ford Health System Trasplante de médula ósea para el tratamiento de la apoplejía
AU2003202988A1 (en) * 2002-01-14 2003-07-30 The Board Of Trustees Of The University Of Illinois Use of modified pyrimidine compounds to promote stem cell migration and proliferation
US20060051860A1 (en) * 2002-11-15 2006-03-09 Kyushu Tlo Company, Limited Method of organ regeneration
ES2294650T3 (es) 2004-09-30 2008-04-01 Reneuron Limited Linea celular.
RU2283121C2 (ru) * 2004-11-29 2006-09-10 Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН Способ лечения инсульта
RU2283119C1 (ru) * 2005-03-29 2006-09-10 Андрей Степанович БРЮХОВЕЦКИЙ Препарат аутологичных гемопоэтических стволовых клеток, способ его получения, криоконсервации и использования для лечения травматической болезни центральной нервной системы
US7569545B2 (en) * 2005-05-20 2009-08-04 Academia Sinica Methods of increasing neurotrophic factor expression
WO2007112084A2 (en) 2006-03-24 2007-10-04 Children's Medical Center Corporation Method to modulate hematopoietic stem cell growth
US9402852B2 (en) 2006-10-20 2016-08-02 Children's Medical Center Corporation Method to enhance tissue regeneration
RU2315618C1 (ru) * 2006-11-02 2008-01-27 ГОУ ВПО "Красноярская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Способ коррекции постишемической когнитивной дисфункции
EP2326330B1 (de) 2008-09-16 2015-01-07 University Of Central Florida Research Foundation, Inc. Zusammensetzungen zur behandlung oder verzögerung des beginns von haarverlust
WO2010091052A2 (en) 2009-02-03 2010-08-12 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
US9056085B2 (en) 2009-02-03 2015-06-16 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
GB0902034D0 (en) 2009-02-06 2009-03-11 Reneuron Ltd Method
WO2012145723A1 (en) * 2011-04-20 2012-10-26 The Regents Of The University Of California Method for combined conditioning and chemoselection in a single cycle
CN112410298A (zh) 2011-12-02 2021-02-26 菲特治疗公司 增强的干细胞组合物
EP2785350B1 (de) 2011-12-02 2018-05-02 Fate Therapeutics, Inc. Verbesserte verfahren zur behandlung von ischämie
WO2014150602A1 (en) 2013-03-15 2014-09-25 Fate Therapeutics, Inc. Cell potency assay for therapeutic potential
RU2647429C1 (ru) * 2017-02-06 2018-03-15 Федеральное государственное автономное образовательное учреждение высшего образования "Дальневосточный федеральный университет" (ДВФУ) Биомедицинский клеточный препарат
RU2720002C1 (ru) * 2018-12-28 2020-04-23 Андрей Степанович БРЮХОВЕЦКИЙ Биомедицинский клеточный продукт для лечения нервных болезней и психических расстройств, способ его получения и его применение
CN114934072B (zh) * 2022-05-18 2023-10-20 华中科技大学同济医学院附属协和医院 一种人心脏瓣膜间质细胞系的永生化构建方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399493A (en) * 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
JPH07504331A (ja) * 1992-03-04 1995-05-18 システミックス，インコーポレイティド 造血幹細胞の培養およびその遺伝子工学
IL122752A (en) * 1995-06-27 2001-07-24 Boehringer Ingelheim Kg Stable preparations for creating propellant-free sprays
GB9518606D0 (en) * 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
RU2129427C1 (ru) * 1996-04-30 1999-04-27 Аникин Александр Юрьевич Способ лечения заболеваний центральной нервной системы
WO1998007841A1 (en) * 1996-08-19 1998-02-26 University Of Massachusetts Embryonic or stem-like cell lines produced by cross species nuclear transplantation
RU2136299C1 (ru) * 1998-04-13 1999-09-10 Тамара Михайловна Воробьева Способ лечения демиелинизирующих расстройств центральной нервной системы

Also Published As

Publication number Publication date
DK1161521T3 (da) 2003-06-16
CN1636053A (zh) 2005-07-06
RU2216336C2 (ru) 2003-11-20
HUP0105168A2 (hu) 2002-05-29
AU762763B2 (en) 2003-07-03
AU2682100A (en) 2000-09-14
HUP0105168A3 (en) 2003-12-29
NO20014091L (no) 2001-08-23
DE60002185T2 (de) 2003-12-18
HK1041284B (en) 2003-10-03
KR20020000216A (ko) 2002-01-05
EP1161521B1 (de) 2003-04-16
WO2000050568A2 (en) 2000-08-31
CA2361401A1 (en) 2000-08-31
HK1041284A1 (en) 2002-07-05
ES2193938T3 (es) 2003-11-16
SK11232001A3 (sk) 2002-01-07
CZ20012651A3 (cs) 2002-01-16
WO2000050568A3 (en) 2000-12-07
JP2002537406A (ja) 2002-11-05
PT1161521E (pt) 2003-08-29
EP1161521A2 (de) 2001-12-12
GB9904281D0 (en) 1999-04-21
PL350297A1 (en) 2002-12-02
DE60002185D1 (de) 2003-05-22
NO20014091D0 (no) 2001-08-23
JP4716575B2 (ja) 2011-07-06

Similar Documents

Publication Publication Date Title
DE60002185D1 (de) Transplantation von hämatopoietischen zellen
DE60231708D1 (de) Somatische pluripotente Zellen
NO20004803L (no) Smilagening og anzurogenin for behandling av Alzheimers sykdom
GB0400167D0 (en) Dopaminergic neurons and proliferation-competent orecursor cells for treating parkinson's disease
GT199600026A (es) Isotiazolonas
NZ509729A (en) Agents with an antidepressive effect
SE9900100D0 (sv) New compounds
LU92433I2 (fr) Olodatérol, ses isomères optiques individuels, mélanges d'énantiomères individuels ou de racémates, ses sels d'addition d'acide avec des acides pharmaceutiquement acceptables, ainsi que ses solvates et/ou ses hydrates, en particulier l'olodatérol et le chlorhydrate d'olodatérol
DE59603216D1 (de) Esterquats und ihre Verwendung zur Herstellung von oberflächenaktiven Mitteln, insbesondere zur Haar- und Körperpflege
DE60029566D1 (de) In-vitro herstellung von transplantierbarem knorpelgewebe
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
EP1769791A3 (de) Therapeutische strategien für die prävention und behandlung der alzeheimer-krankheit
GB2407821A (en) Generation of neural stem cells from undifferentiated human embryonic stem cells
FI901289A7 (fi) Muistia ja oppimista parantava tai kognitiivisten tai psykoottisten häiriöiden hoidossa käytettävä koostumus, joka sisältää D-sykloseriiniä ja D-alaniinia
AU2003220096A1 (en) Methods for alzheimer's disease treatment and cognitive enhancement
WO2003039454A3 (en) Beta-secretase inhibitors and methods of use
WO2003102016A3 (en) Amyloid peptide inactivating enzyme to treat alzheimer's disease
WO1998013488A3 (en) Process for the determination of app secretase modulators and the use thereof as agents in the treatment of alzheimer's disease
ATE330001T1 (de) Therapeutische verwendung mesenchymaler stromazellen
PT983272E (pt) Nova classe de compostos fotoactivos derivados de benzoporfirina
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
CA95615S (en) Tanned hide
ATE464048T1 (de) Behandlung von alzheimer-krankheit und verwandten zuständen
PT1152762E (pt) Utilizacao de desoxipeganina no tratamento da demencia de alzheimer
BR0114884A (pt) Compostos calcilìticos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1161521

Country of ref document: EP

REN Ceased due to non-payment of the annual fee